Hong Kong Stocks Fall on Uncertainty in Further Stimulus; Pharma Firms Lead Decline

MT Newswires Live
2024-10-14

Hong Kong stocks fell on Monday following a holiday as investor sentiment waned after China's finance ministry failed to specify further stimulus measures for the economy.

The Hang Seng Index fell 0.75%, or 159.11 points, at 21,092.87. The Hang Seng China Enterprises index lost 0.54%, or 40.80 points, at 7,579.94.

Finance minister Lan Foan hinted at significantly increasing debt at a press conference held over the weekend but failed to provide any details on the size of the stimulus, leaving investors speculating.

Investor sentiment also took a hit as data from the statistics bureau on Sunday showed consumer inflation decelerating to 0.4% in September from 0.6% in August and producer prices plunging 2.8% for the 24th straight month, according to an SCMP report.

Pharma companies BeiGene (HKG:6160, SHA:688235), Innovent Biologics (HKG:1801), and CSPC Pharmaceutical (HKG:1093) led the decline with each of the companies' shares falling 5% at the close.

Sporting goods manufacturer Anta Sports Products (HKG:2020) also plunged 9%, with EV maker BYD (HKG:1211, SHE:002594) dropping 4% at Monday's close.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10